Tuesday, 30 November 2010

Diltam




Diltam may be available in the countries listed below.


Ingredient matches for Diltam



Diltiazem

Diltiazem is reported as an ingredient of Diltam in the following countries:


  • Peru

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Diltam in the following countries:


  • Ireland

International Drug Name Search

Sunday, 28 November 2010

Bartil




Bartil may be available in the countries listed below.


Ingredient matches for Bartil



Butamirate

Butamirate citrate (a derivative of Butamirate) is reported as an ingredient of Bartil in the following countries:


  • Greece

International Drug Name Search

Mitoxantrone Baxter




Mitoxantrone Baxter may be available in the countries listed below.


Ingredient matches for Mitoxantrone Baxter



Mitoxantrone

Mitoxantrone is reported as an ingredient of Mitoxantrone Baxter in the following countries:


  • Portugal

Mitoxantrone dihydrochloride (a derivative of Mitoxantrone) is reported as an ingredient of Mitoxantrone Baxter in the following countries:


  • Greece

  • Singapore

  • Turkey

International Drug Name Search

Friday, 26 November 2010

Fenazil




Fenazil may be available in the countries listed below.


Ingredient matches for Fenazil



Promethazine

Promethazine hydrochloride (a derivative of Promethazine) is reported as an ingredient of Fenazil in the following countries:


  • Italy

  • Malta

International Drug Name Search

Vandral Retard SinGad




Vandral Retard SinGad may be available in the countries listed below.


Ingredient matches for Vandral Retard SinGad



Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Vandral Retard SinGad in the following countries:


  • Denmark

International Drug Name Search

Plidan




Plidan may be available in the countries listed below.


Ingredient matches for Plidan



Diazepam

Diazepam is reported as an ingredient of Plidan in the following countries:


  • Argentina

Pargeverine

Pargeverine hydrochloride (a derivative of Pargeverine) is reported as an ingredient of Plidan in the following countries:


  • Peru

  • Venezuela

International Drug Name Search

Thursday, 25 November 2010

Fringanor




Fringanor may be available in the countries listed below.


Ingredient matches for Fringanor



Lamotrigine

Lamotrigine is reported as an ingredient of Fringanor in the following countries:


  • Luxembourg

International Drug Name Search

Monday, 22 November 2010

Apo-Butorphanol




Apo-Butorphanol may be available in the countries listed below.


Ingredient matches for Apo-Butorphanol



Butorphanol

Butorphanol tartrate (a derivative of Butorphanol) is reported as an ingredient of Apo-Butorphanol in the following countries:


  • Canada

International Drug Name Search

Thursday, 18 November 2010

Cincol




Cincol may be available in the countries listed below.


Ingredient matches for Cincol



Naphazoline

Naphazoline nitrate (a derivative of Naphazoline) is reported as an ingredient of Cincol in the following countries:


  • Poland

Zinc Sulfate

Zinc Sulfate is reported as an ingredient of Cincol in the following countries:


  • Poland

International Drug Name Search

Friday, 12 November 2010

Aldonar




Aldonar may be available in the countries listed below.


Ingredient matches for Aldonar



Spironolactone

Spironolactone is reported as an ingredient of Aldonar in the following countries:


  • Portugal

International Drug Name Search

Tuesday, 9 November 2010

Pentoxi Retard




Pentoxi Retard may be available in the countries listed below.


Ingredient matches for Pentoxi Retard



Pentoxifylline

Pentoxifylline is reported as an ingredient of Pentoxi Retard in the following countries:


  • Romania

International Drug Name Search

Friday, 5 November 2010

Postuitrin




Postuitrin may be available in the countries listed below.


Ingredient matches for Postuitrin



Oxytocin

Oxytocin is reported as an ingredient of Postuitrin in the following countries:


  • Turkey

International Drug Name Search

Thursday, 4 November 2010

Piperacilina Tazobactam Combino Pharm




Piperacilina Tazobactam Combino Pharm may be available in the countries listed below.


Ingredient matches for Piperacilina Tazobactam Combino Pharm



Piperacillin

Piperacillin sodium salt (a derivative of Piperacillin) is reported as an ingredient of Piperacilina Tazobactam Combino Pharm in the following countries:


  • Spain

Tazobactam

Tazobactam sodium salt (a derivative of Tazobactam) is reported as an ingredient of Piperacilina Tazobactam Combino Pharm in the following countries:


  • Spain

International Drug Name Search

Wednesday, 3 November 2010

Oflohexal




Oflohexal may be available in the countries listed below.


Ingredient matches for Oflohexal



Ofloxacin

Ofloxacin is reported as an ingredient of Oflohexal in the following countries:


  • Georgia

  • Germany

International Drug Name Search

Tuesday, 2 November 2010

Naropin


Naropin is a brand name of ropivacaine, approved by the FDA in the following formulation(s):


NAROPIN (ropivacaine hydrochloride monohydrate - injectable; injection)



  • Manufacturer: APP PHARMS

    Approval date: September 24, 1996

    Strength(s): 10MG/ML [RLD], 2MG/ML, 5MG/ML, 7.5MG/ML

Has a generic version of Naropin been approved?


No. There is currently no therapeutically equivalent version of Naropin available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Naropin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Methods and compositions for the treatment of pain utilizing ropivacaine
    Patent 5,670,524
    Issued: September 23, 1997
    Inventor(s): Eek; Arne Torsten
    Assignee(s): Astra AB
    Use of a pharmaceutically acceptable salt of ropivacaine for the manufacture of a pharmaceutical preparation with sensoric block and minimal motor blockade.
    Patent expiration dates:

    • May 26, 2014
      ✓ 
      Patent use: METHOD OF TREATING PAIN USING A PHARMACEUTICALLY ACCEPTABLE SALT OF ROPIVACAINE AND ADMINISTERING A COMPOSITION CONTAINING LESS THAN 0.25% BY WEIGHT OF ROPIVACAINE
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Methods and compositions for the treatment of pain utilizing ropivacaine
    Patent 5,834,489
    Issued: November 10, 1998
    Inventor(s): Eek; Arne Torsten
    Assignee(s): AB Astra
    Use of a pharmaceutically acceptable salt of ropivacaine for the manufacture of a pharmaceutical preparation with sensoric block and minimal motor blockade.
    Patent expiration dates:

    • May 26, 2014
      ✓ 
      Patent use: METHOD OF TREATING PAIN USING A PHARMACEUTICALLY ACCEPTABLE SALT OF ROPIVACAINE AND ADMINISTERING A COMPOSITION CONTAINING LESS THAN 0.5% BY WEIGHT OF ROPIVACAINE
      ✓ 
      Drug substance
      ✓ 
      Drug product



See also...

  • Naropin Consumer Information (Wolters Kluwer)
  • Naropin Consumer Information (Cerner Multum)
  • Naropin Advanced Consumer Information (Micromedex)
  • Ropivacaine Consumer Information (Wolters Kluwer)
  • Ropivacaine Consumer Information (Cerner Multum)
  • Ropivacaine Injection Advanced Consumer Information (Micromedex)

Monday, 1 November 2010

Betamethasone Dipropionate Lotion



Pronunciation: bay-ta-METH-a-sone die-PRO-pee-oh-nate
Generic Name: Betamethasone Dipropionate
Brand Name: Generic only. No brands available.


Betamethasone Dipropionate Lotion is used for:

Reducing itching, redness, and swelling associated with many skin conditions.


Betamethasone Dipropionate Lotion is a topical corticosteroid. It works by depressing the formation, release, and activity of different cells and chemicals that cause swelling, redness, and itching.


Do NOT use Betamethasone Dipropionate Lotion if:


  • you are allergic to any ingredient in Betamethasone Dipropionate Lotion or to another corticosteroid (eg, prednisone)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Betamethasone Dipropionate Lotion:


Some medical conditions may interact with Betamethasone Dipropionate Lotion. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have thinning of the skin, a skin infection, tuberculosis, chickenpox, shingles, measles, a positive TB skin test, or have recently been vaccinated

Some MEDICINES MAY INTERACT with Betamethasone Dipropionate Lotion. Because little, if any, of Betamethasone Dipropionate Lotion is absorbed into the blood, the risk of it interacting with another medicine is low.


Ask your health care provider if Betamethasone Dipropionate Lotion may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Betamethasone Dipropionate Lotion:


Use Betamethasone Dipropionate Lotion as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Shake well before each use.

  • Place nozzle of the bottle very close to the affected area and gently squeeze a small amount of medicine onto the affected area. Do not touch the nozzle to the skin. Gently rub the medicine in until it is evenly distributed. Wash your hands after applying Betamethasone Dipropionate Lotion, unless your hands are part of the treated area. Do not apply Betamethasone Dipropionate Lotion to the face, groin, or armpit unless otherwise directed by your doctor.

  • Do not cover the treating area with bandages, wrappings, or other dressings unless advised to do so by your health care provider.

  • If you miss a dose of Betamethasone Dipropionate Lotion, apply it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Betamethasone Dipropionate Lotion.



Important safety information:


  • Betamethasone Dipropionate Lotion is for external use only. Avoid contact with the eyes. If you get Betamethasone Dipropionate Lotion in your eyes, immediately flush with cool tap water.

  • Do not use Betamethasone Dipropionate Lotion for other skin conditions at a later time.

  • Betamethasone Dipropionate Lotion has a corticosteroid in it. Before you start any new medicine, check the label to see if it has a corticosteroid in it too. If it does or if you are not sure, check with your doctor or pharmacist.

  • If Betamethasone Dipropionate Lotion was prescribed to treat the diaper area of a child, avoid using tight-fitting diapers or plastic pants.

  • Check with your doctor before you have any vaccinations while you are using Betamethasone Dipropionate Lotion.

  • Corticosteroids may affect growth rate in CHILDREN and teenagers in some cases. They may need regular growth checks while they use Betamethasone Dipropionate Lotion.

  • Betamethasone Dipropionate Lotion should not be used in CHILDREN younger than 13 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Betamethasone Dipropionate Lotion while you are pregnant. It is not known if Betamethasone Dipropionate Lotion is found in breast milk. If you are or will be breast-feeding while you use Betamethasone Dipropionate Lotion, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Betamethasone Dipropionate Lotion:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Dry skin; mild, temporary stinging when applied.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); acne-like rash; burning, cracking, irritation, or peeling not present before you began using Betamethasone Dipropionate Lotion; excessive hair growth; inflamed hair follicles; inflammation around the mouth; muscle weakness; thinning, softening, or discoloration of the skin; unusual weight gain, especially in the face.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.



If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include increased thirst or urination; muscle weakness; unusual weight gain, especially in the face.


Proper storage of Betamethasone Dipropionate Lotion:

Store Betamethasone Dipropionate Lotion at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not freeze. Keep Betamethasone Dipropionate Lotion out of the reach of children and away from pets.


General information:


  • If you have any questions about Betamethasone Dipropionate Lotion, please talk with your doctor, pharmacist, or other health care provider.

  • Betamethasone Dipropionate Lotion is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Betamethasone Dipropionate Lotion. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Betamethasone Dipropionate resources


  • Betamethasone Dipropionate Use in Pregnancy & Breastfeeding
  • Betamethasone Dipropionate Drug Interactions
  • Betamethasone Dipropionate Support Group
  • 13 Reviews for Betamethasone Dipropionate - Add your own review/rating


Compare Betamethasone Dipropionate with other medications


  • Atopic Dermatitis
  • Dermatitis
  • Dermatological Disorders
  • Lichen Planus
  • Lichen Sclerosus